Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ALRT-1057 exhibits high incidence of complete remission

May 31, 1996

U.S. Bioscience and Alza embark on marketing agreement for altretamine

May 31, 1996

Ligand reveals RXR-selective retinoid

May 31, 1996

MF-13 revealed as a selective tumor apoptosis-inducing agent

May 31, 1996

NSC-652287D shows important antitumor activity

May 31, 1996

Dainippon reveals compounds with antitumor activity

May 31, 1996

Spicamycin derivative revealed

May 31, 1996

Otsuka reveals matrix metalloproteinase inhibitors

May 31, 1996

Ciba-Geigy describes CGP-59326, a powerful antitumor agent

May 31, 1996

University of Pittsburgh research reveals GGTI-298, a new geranylgeranyltransferase-1 inhibitor

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ASH 2025: New blood cancer therapies trump chemo, older drugs
BioWorld
Targeted therapies and immunotherapies continue to show better results than chemotherapy in investigator-initiated and company-sponsored cancer trials, and newer...